Literature DB >> 29509433

Reduced skeletal muscle phosphocreatine concentration in type 2 diabetic patients: a quantitative image-based phosphorus-31 MR spectroscopy study.

Erika M Ripley1, Geoffrey D Clarke1,2,3, Vala Hamidi2, Robert A Martinez2, Floyd D Settles1, Carolina Solis2, Shengwen Deng3, Muhammad Abdul-Ghani2, Devjit Tripathy2, Ralph A DeFronzo2.   

Abstract

Mitochondrial function has been examined in insulin-resistant (IR) states including type 2 diabetes mellitus (T2DM). Previous studies using phosphorus-31 magnetic resonance spectroscopy (31P-MRS) in T2DM reported results as relative concentrations of metabolite ratios, which could obscure differences in phosphocreatine ([PCr]) and adenosine triphosphate concentrations ([ATP]) between T2DM and normal glucose tolerance (NGT) individuals. We used an image-guided 31P-MRS method to quantitate [PCr], inorganic phosphate [Pi], phosphodiester [PDE], and [ATP] in vastus lateralis (VL) muscle in 11 T2DM and 14 NGT subjects. Subjects also received oral glucose tolerance test, euglycemic insulin clamp, 1H-MRS to measure intramyocellular lipids [IMCL], and VL muscle biopsy to evaluate mitochondrial density. T2DM subjects had lower absolute [PCr] and [ATP] than NGT subjects (PCr 28.6 ± 3.2 vs. 24.6 ± 2.4, P < 0.002, and ATP 7.18 ± 0.6 vs. 6.37 ± 1.1, P < 0.02) while [PDE] was higher, but not significantly. [PCr], obtained using the traditional ratio method, showed no significant difference between groups. [PCr] was negatively correlated with HbA1c ( r = -0.63, P < 0.01) and fasting plasma glucose ( r = -0.51, P = 0.01). [PDE] was negatively correlated with Matsuda index ( r = -0.43, P = 0.03) and M/I ( r = -0.46, P = 0.04), but was positively correlated with [IMCL] ( r = 0.64, P < 0.005), HbA1c, and FPG ( r = 0.60, P = 0.001). To summarize, using a modified, in vivo quantitative 31P-MRS method, skeletal muscle [PCr] and [ATP] are reduced in T2DM, while this difference was not observed with the traditional ratio method. The strong inverse correlation between [PCr] vs. HbA1c, FPG, and insulin sensitivity supports the concept that lower baseline skeletal muscle [PCr] is related to key determinants of glucose homeostasis.

Entities:  

Keywords:  ATP; insulin resistance; mitochondrial function; phosphocreatine; phosphorus-31 magnetic resonance spectroscopy; skeletal muscle metabolism; type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 29509433      PMCID: PMC6139498          DOI: 10.1152/ajpendo.00426.2017

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  61 in total

Review 1.  Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.

Authors:  Graham J Kemp; Martin Meyerspeer; Ewald Moser
Journal:  NMR Biomed       Date:  2007-10       Impact factor: 4.044

2.  Morphometric documentation of abnormal intramyocellular fat storage and reduced glycogen in obese patients with Type II diabetes.

Authors:  K Levin; H Daa Schroeder; F P Alford; H Beck-Nielsen
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

3.  Effects of pioglitazone on intramyocellular fat metabolism in patients with type 2 diabetes mellitus.

Authors:  Mandeep Bajaj; Rais Baig; Swangjit Suraamornkul; Lou Jean Hardies; Dawn K Coletta; Gary W Cline; Adriana Monroy; Shailja Koul; Apiradee Sriwijitkamol; Nicolas Musi; Gerald I Shulman; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2010-02-15       Impact factor: 5.958

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance.

Authors:  Muhammad A Abdul-Ghani; Florian L Muller; Yuhong Liu; Alberto O Chavez; Bogdan Balas; Pengou Zuo; Zhi Chang; Devjit Tripathy; Rucha Jani; Marjorie Molina-Carrion; Adriana Monroy; Franco Folli; Holly Van Remmen; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-01       Impact factor: 4.310

6.  Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited.

Authors:  John J Dubé; Francesca Amati; Maja Stefanovic-Racic; Frederico G S Toledo; Sarah E Sauers; Bret H Goodpaster
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-04       Impact factor: 4.310

7.  Role of diacylglycerol activation of PKCθ in lipid-induced muscle insulin resistance in humans.

Authors:  Julia Szendroedi; Toru Yoshimura; Esther Phielix; Chrysi Koliaki; Mellissa Marcucci; Dongyan Zhang; Tomas Jelenik; Janette Müller; Christian Herder; Peter Nowotny; Gerald I Shulman; Michael Roden
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

Review 8.  Muscular mitochondrial dysfunction and type 2 diabetes mellitus.

Authors:  Vera B Schrauwen-Hinderling; Michael Roden; M Eline Kooi; Matthijs Kc Hesselink; Patrick Schrauwen
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2007-11       Impact factor: 4.294

9.  Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes.

Authors:  Michaela Scheuermann-Freestone; Per L Madsen; David Manners; Andrew M Blamire; Robin E Buckingham; Peter Styles; George K Radda; Stefan Neubauer; Kieran Clarke
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  Mechanisms underlying the onset of oral lipid-induced skeletal muscle insulin resistance in humans.

Authors:  Bettina Nowotny; Lejla Zahiragic; Dorothea Krog; Peter J Nowotny; Christian Herder; Maren Carstensen; Toru Yoshimura; Julia Szendroedi; Esther Phielix; Peter Schadewaldt; Nanette C Schloot; Gerald I Shulman; Michael Roden
Journal:  Diabetes       Date:  2013-03-01       Impact factor: 9.461

View more
  9 in total

1.  Muscular carnosine is a marker for cardiorespiratory fitness and cardiometabolic risk factors in men with type 1 diabetes.

Authors:  Laura Brugnara; Ana Isabel García; Serafín Murillo; Josep Ribalta; Guerau Fernandez; Susanna Marquez; Miguel Angel Rodriguez; Maria Vinaixa; Núria Amigó; Xavier Correig; Susana Kalko; Jaume Pomes; Anna Novials
Journal:  Eur J Appl Physiol       Date:  2022-03-17       Impact factor: 3.078

Review 2.  Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Mahnoor Mir; Robert Chilton
Journal:  Heart Fail Rev       Date:  2022-01       Impact factor: 4.214

3.  Greater fatigability and motor unit discharge variability in human type 2 diabetes.

Authors:  Jonathon W Senefeld; Kevin G Keenan; Kevin S Ryan; Sarah E D'Astice; Francesco Negro; Sandra K Hunter
Journal:  Physiol Rep       Date:  2020-07

Review 4.  Increased Adenine Nucleotide Degradation in Skeletal Muscle Atrophy.

Authors:  Spencer G Miller; Paul S Hafen; Jeffrey J Brault
Journal:  Int J Mol Sci       Date:  2019-12-21       Impact factor: 5.923

Review 5.  Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy.

Authors:  Mouhamed Nashawi; Mahmoud S Ahmed; Toka Amin; Mujahed Abualfoul; Robert Chilton
Journal:  World J Cardiol       Date:  2021-12-26

Review 6.  Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases.

Authors:  Ana Pérez-García; Marta Torrecilla-Parra; Mario Fernández-de Frutos; Yolanda Martín-Martín; Virginia Pardo-Marqués; Cristina M Ramírez
Journal:  Biomolecules       Date:  2022-01-26

7.  Exercise and Creatine Supplementation to Augment the Adaptation of Exercise Training Among Breast Cancer Survivors Completing Chemotherapy: Protocol for an Open-label Randomized Controlled Trial (the THRIVE Study).

Authors:  Darpan I Patel; Angela Gonzalez; Crisann Moon; Monica Serra; Preston Blake Bridges; Daniel Hughes; Geoffrey Clarke; Lisa Kilpela; Rozmin Jiwani; Nicolas Musi
Journal:  JMIR Res Protoc       Date:  2022-04-01

8.  Older adults with sarcopenia have distinct skeletal muscle phosphodiester, phosphocreatine, and phospholipid profiles.

Authors:  James Matthew Hinkley; Heather H Cornnell; Robert A Standley; Emily Y Chen; Niven R Narain; Bennett P Greenwood; Valerie Bussberg; Vladimir V Tolstikov; Michael A Kiebish; Fanchao Yi; Rick B Vega; Bret H Goodpaster; Paul M Coen
Journal:  Aging Cell       Date:  2020-05-28       Impact factor: 9.304

9.  Muscle phosphorus metabolites in sarcopenia.

Authors:  J Matthew Hinkley; Paul M Coen
Journal:  Aging (Albany NY)       Date:  2020-08-28       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.